Associated Papers
Antitumor Activity of a Novel Tyrosine Kinase Inhibitor AIU2001 Due to Abrogation of the DNA Damage Repair in Non-Small Cell Lung Cancer Cells.
Ryu H et al.
International Journal of Molecular Sciences, 2019
Clinical Value of Pharmacogenomic Testing in a Patient Receiving FOLFIRINOX for Pancreatic Adenocarcinoma.
Velez-Velez LM et al.
Frontiers in Pharmacology, 2018
Select a paper to view details